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1.   Abstract  
Background  
Femoral   nerve   block   (FNB)   is   commonly   used   as   continuous   infusion   for  
postoperative   analgesia   after   total   knee   arthroplasty   (TKA).   The   discussion,   if   an  
additional  sciatic  nerve  block  (SNB)  improves  analgesic  outcome  is  controversial.   
Objective  and  Methods  
To  analyze  the  impact  of  a  continuous  FNB  (cFNB)  compared  to  the  combination  of  
cFNB   and   single   shot   sciatic   nerve   block   (ssSNB)   we   performed   a   retrospective  
study   including  all  patients  who  underwent  an  unilateral,  elective  TKA  using  one  of  
the  above-­mentioned   techniques   for  perioperative  analgesia  of   the   last  10  years   in  
the  Balgrist  University  Balgrist.  
Results  
A   total   of   1’015   ASA   I-­III   patients   could   be   analyzed   showing   comparable   groups  
concerning  patient  and  surgical  characteristics.  The  visual  analogue  analgesia  (VAS)  
scores  at   rest  were  significantly   reduced   in   the  cFNB  &  ssSNB  group  compared   to  
the  cFNB  group  at  12h  (VAS  15  ±  5  vs.  VAS  25  ±  5;;  p=  0.04)  and  24  h  (VAS  15  ±  5  
vs.   VAS   35   ±   7;;   p=   0.04).   At   48h   the   VAS   scores   were   comparable   between   the  
groups   (p   =   0.850).   The  morphine   consumption   was   also   reduced   in   the   cFNB   &  
ssSNB  group  compared  to  the  cFNB  group  during  the  first  24h  (4  ±  3  mg  vs.  11  ±  6  
mg;;   p<   0.01)   and   comparable   at   48h   (7   ±   3   mg   vs.   8   ±   5   mg;;   p=   0.320).   The  
functional   scores  were   comparable   between   the   groups   prior   to   surgery   and   there  
was  no  difference  between   the  groups  at   the  clinical   follow  up  at  3  months  and  12  
months.  The  incidence  of  cFNB  dislocation  was  similar  with  1%  in  both  groups.  Also  
the   incidence  of   reported  stumbling   (5%)  and   reported   falling   (0.9%)  was  similar   in  
both  groups.  Morphine-­associated  side  effects  like  nausea  and  vomiting  were  higher  
in  the  cFNB  group  compared  to  the  cFNB  &  ssSNB  group  (8%  vs.  3%;;  p<  0.01).  
Conclusion  and  Implications  
The  use  of  and  additional  ssSNB  to  a  cFNB  has  a  better  analgesia  effect  for  the  first  
24  hours  reducing  the  amount  of  opiods  used  and  the  opioid-­associated  nausea  and  
vomiting.   Despite   these   results   are   from   a   retrospective   study,   the   use   of   an  
additional  ssSNB  seems  to  be  associated  with  a  better  analgesic  outcome.  However,  
future  investigations  assessing  the  analgesic  effect  at  rest  and  with  motion  as  well  as  
the  functional  outcome  are  warranted.  
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2.   List  of  Abbreviations  
FNB:           femoral  nerve  block  
GA:           general  anesthesia  
KSS:           Knee  Society  Score  
LIA:         local  infiltration  analgesia  
RA:         regional  anesthesia  
RCT:         randomized  controlled  trial  
ssFNB/cFNB:   single  shot  femoral  nerve  block  /  continuous  femoral  nerve  block  
SNB:         sciatic  nerve  block  
ssSNB/cSNB:   single  shot  sciatic  nerve  block  /  continuous  sciatic  nerve  block  
SPA:         spinal  anesthesia  
TKA:         total  knee  arthroplasty  
VAS:           visual  analogue  scale  
WOMAC:      Western  Ontario  and  McMaster  Universities  Arthritis  Index  
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3.   Introduction  
  
3.1.  Background  
The  goal  of  total  knee  arthroplasty  (TKA)  is  to  relieve  pain,  improve  quality  of  life  and  
maintain  or  increase  knee  function.  The  most  common  indication  for  the  procedure  is  
the  failure  of  conservative  and  analgesic  treatments  and  the  goal  of  relieving  arthritis-­
associated  knee  pain.  (1)  Nevertheless,  it  is  well  known  that  patients  undergoing  TKA  
are   exposed   to   acute   postoperative   pain.   Therefore,   an   adequate   analgesia   to  
facilitate   and   accelerate   rehabilitation   is   essential.   (2)   Moreover,   persistent   post-­
surgical  pain  is  a  major  problem  after  TKA  with  implications  in  rehabilitation,  clinical  
outcome  and   further   costs   to   the  health   system.   (3-­5)  Therefore,   the  best   possible  
analgesia  regimen  is  required.  
The  superiority  of  regional  anesthesia  (RA)  techniques  over  general  anesthesia  (GA)  
with   systemic  opioid  analgesia   is  well   established   in   the   literature.   (6,   7)  The  main  
advantages  of  RA  consist  on  a  better  quality  of  analgesia,  reduced  use  of  systemic  
opioids  and  fewer  opioid-­specific  systemic  side  effects  like  nausea,  vomiting,  pruritus,  
respiratory  depression,  urinary   retention  and  obstipation  and   therefore  an   improved  
postoperative  recovery  and  early  mobilization.  (8,  9).  
3.2.  The  Knee  Joint  
The  knee  is  a  complex  joint,  where  all  anatomical  structures  have  their  specific  and  
relevant   role   in  allowing  a   fine  adaptation  of   lower   limb  mobility   (1).  To  achieve  an  
anesthesia   of   the   knee   using   only   peripheral   nerve   blocks,   three   nerves   must   be  
blocked:  the  femoral,  sciatic  and  obturator  nerve.    
The   femoral   nerve   arises   from   the   lumbar   plexus   (L2-­L4).   It   passes   under   the  
inguinal   ligament   and   supplies   the   quadriceps  muscles,   partially   the   pectineus  and  
gives  some  branches  to  the  adductor  muscles  and  innvervates  not  only  the  knee  but  
also  the  hip  joint.  The  saphenous  nerve  is  a  terminal  cutaneous  branch  of  the  femoral  
nerve  which   runs  down   the  medial  aspect  of   the  calf   innervating   its  skin  and  gives  
branches  to  the  medial  capsule  of  the  ankle.  (10)    
The  obturator  nerve  arises  like  the  femoral  nerve  from  the  lumbar  plexus  (L2-­L4).  It  
supplies  the  adductor  thigh  muscles  and  in  30%  of  the  patients  the  skin  of  the  medial  
part  of  the  thigh.  It  innervates  the  hip  and  the  knee  joint.  
The  sciatic  nerve  is  derives  from  the  lumbar  and  sacral  plexus  (L4-­L5,  S1-­S3)  and  is  
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from   its   beginning   divided   into   the   tibial   (medial)   and   common   peroneal   (lateral)  
nerves  within  a  common  connective   tissue  sheath.  The  sciatic  nerve  enters   the   leg  
posteriorily   and   runs   down   the   back   of   the   thigh   innervating   the   hip   and   the   knee  
joint.   It  splits   into  the  tibial  and  common  peroneal  nerve  at   the  apex  of  the  popliteal  
fossa.   The   tibial   nerve,   the   larger   or   both   divisions,   runs   vertically   through   the  
popliteal   fossa   directly   underneath   the   fascia   and   is   the   most   superficial   of   the  
neurovascular   structures   behind   the   knee.   It   supplies   the   superficial   and   deep  
hamstring   muscles   as   well   as   the   gastrocnemius   and   soleus   muscles   and   gives  
some  braches  to  the  adductors  of  the  leg.  The  common  peroneal  nerve  follows  after  
the  division   from   the   tibial   nerve   the   tendon  of   the  biceps   femoris   along   the  upper  
lateral  margin  of  the  popliteal  fossa  to  the  back  of  the  head  of  the  fibula,  where  the  
nerve  winds   round   its  neck  and  passes  deep   to   the  peroneus   longus  muscles  and  
divides   into   the   superficial   and   deep   peroneal   nerves.   It   supplies   the   anterior   and  
lateral  compartments  of  the  leg  including  the  peroneal  muscles.    
Despite  the  triple  innervation  of  the  knee  joint,  only  the  FNB  is  considered  the  golden  
standard   for   TKA.   However,   the   influence   of   a   combined   technique   has   not   been  
broadly   analyzed   yet   and   an   unequivocal   evidence   for   its   better   pain   control   is  
lacking.  (11-­13).    
3.2.    Summary  of  the  Current  Literature  
Current   literature   shows   that   a   cNFB   is   often   placed   for   TKA   with   superior   pain  
control   compared   to   ssFNB.   (14)  When   used   together   or   without   a   ssSNB,   cFNB  
showed   decreased   pain   and   /   or   opioid   use   when   compared   with   morphine   PCA  
control  or  placebo  infusion,  (15-­18)  and  continuous  sciatic  nerve  block  proved  to  be  
superior   to   a   single-­shot   nerve   block   after   cFNB   (19)   and   after   continuous   lumbar  
plexus  block  (cLPB).  (20)  However,  the  primary  outcome  in  the  study  by  Wegener  et  
al.   (19)  was   not   pain   or  morphine   consumption   after   surgery   but   time-­to-­discharge  
readiness.  
When   a   FNB   was   compared   with   epidural   analgesia   (EDA),   the   neuraxial   block  
provided   better   analgesia.   This   might   be   anticipated   given   the   fact   that   a   femoral  
block  does  not  cover  the  entire  surgical  area.  (21)  However,  if  a  SNB  was  added  to  a  
cFNB,   pain   scores   and/or   opioid   consumption   were   similar   to   an   EDA.   (22,   23)  
However,  also   in   these  studies  pain  scores  or  morphine  consumption  were  not   the  
primary   outcome.   As   predicted,   a   single-­shot   or   continuous   sciatic   nerve   block  
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administered   in  addition   to  a  cFNB  was  superior   to  a  cFNB  or  cLPB  alone.   (23-­26)  
The   possible   advantage   of   the   LPB   is   the   additional   block   of   the   obturator   nerve.  
Considering  studies  with  the  use  of  a  cLPB  combined  to  an  SNB,  pain  scores  were  
decreased   compared   to   a  morphine   PCA   (27)   and   similar   to   an   EDA.   (28)   In   one  
study  using   ropivacaine  no  difference   in  analgesia  was   registered  comparing  cLPB  
versus  ssLPB  when  both  were  combined  with  a  ssSNB.  (29)  However,  another  study  
using   levobupivacaine   did   demonstrate   improved   pain   control   with   a   cLPB   versus  
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4.  Objectives  
Every  invasive  procedure  comes  with  certain  risks  and  is  only  routinely  applied  if  the  
advantages   outweigh   the   disadvantages.   The   beneficial   effect   of   FNB   in   the  
perioperative  pain  management  for  TKA  has  already  been  proven,  (12)  the  additional  
block  of  the  sciatic  nerve  to  a  femoral  catheter  is  still  controversial.  (11,  31)  However,  
up  to  two-­thirds  of  patients  with  FNB  continue  to  complain  of  posterior  
knee   pain.   (32)  Moreover,   performing   a   sciatic   nerve   block   is   challenging   and   not  
without  risk.  (33)  
At   the  Balgrist  University  Hospital  TKA  are  always  performed   in  SPA  or  GA  with  a  
cFNB  &  ssSNB  for  a  varus  knee  deformities  and  with  a  cFNB  in  the  case  of  a  valgus  
knee  deformity.  The  reason  for  not  performing  an  SNB  in  a  valgus  deformity  is  due  to  
the   elongation   of   the   SN   with   the   risk   of   nerve   damage   that   has   to   be   assessed  
immediately   after   surgery.   Considering   the   increasing   number   of   TKAs   performed  
worldwide,   a   study   focusing   on   the   optimal   perioperative   analgesia   is   of   outmost  
interest.  (34)  
The   primary   aim   of   this   study   was   the   assessment   of   pain   (VAS:   visual   analogue  
scale;;   VAS:   0   =   no   pain;;   VAS:100   =   worst   imaginable   pain)   and   morphine  
consumption  comparing   the  combination  cFNB  &  ssSNB  with  cFNB  alone   for  TKA.  
Additionally,   the   impact   of   both   analgesia   regimens   on   the   functional   outcome  
according   to   specific   scores   (KSS   and   WOMAC)   was   analyzed.   Side   effects   like  
opioid-­associated   nausea   and   vomiting,   catheter   dislocation,   stumbling   and   falling  
were  also  recorded.  
  
  




The  study  was  approved  by  the  local  Ethics  Committee  (Kantonale  Ethikkommission  
Zürich,  KEK-­ZH-­Nr:  2015-­0300).  
5.2.  Data  Search  
The  charts  of  all  patients  who  underwent  an  unilateral,  elective  TKA  using  a  cFNB  or  
the  combination  of  a  cFNB  and  a  ssSNB  of  the  last  10  years  in  the  Balgrist  University  
Balgrist   were   reviewed   assessing   anesthesia,   PACU   and   ward   data   as   well   as  
preoperative  and   follow  up   functional  outcome  scores  by   the  master   student   (S.B.)  
and  reviewed  by  the  tutor  (J.A.A.)  
5.3.  Inclusion  and  Exclusion  Criteria  
Spinal  and  general  anesthesia  regimens  were  included.  Block  failures  recognized  at  
induction  were  excluded   from   the  analysis.  Patients  with  cSNB  were  also  excluded  
from  the  analysis  
5.4.  Statistics    
Categorical   data   were   compared   using   Fisher   exact   test.   Ordinal   data   and  
continuous   data   that   were   not   normally   distributed   are   presented   as   median   and  
range.  These  data  were  compared  between  groups  using   the  Mann-­Whitney  U  test  
and  within  groups  using  Wilcoxon  signed  rank   test.  Normally  distributed  continuous  
data   are   presented   as   mean   and   ±   SD.   These   data   were   compared   using   the  
unpaired  t  test.  
A   p   <   0.05   was   considered   to   be   significant.   Statistical   analyses   were   performed  
using  computer  SigmaStat  Version  16  (SPSS  Science,  Chicago,  IL).  
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6.   Results  
A   total   of   1’015   ASA   I-­III   patients   could   be   analyzed   showing   comparable   groups  
concerning  patient  and  surgical  characteristics.  (Table  1)    
  
The  visual  analogue  analgesia  (VAS)  scores  at  rest  were  significantly  reduced  in  the  
cFNB  &  ssSNB  group  compared  to  the  cFNB  group  at  12h  (VAS  15  ±  5  vs.  VAS  25  ±  
5;;  p=  0.04)  and  24h  (VAS  15  ±  5  vs.  VAS  35  ±  7;;  p=  0.04).  At  48h  the  VAS  scores  
were  comparable  between  the  groups  (VAS  10  ±  5  vs.  VAS  10  ±  5;;  p  =  0.850).    
The  morphine  consumption  was  also  reduced  in  the  cFNB  &  ssSNB  group  compared  
to   the   cFNB   group   during   the   first   24h   (4   ±   3   mg   vs.   11   ±   6   mg;;   p<   0.01)   and  
comparable  at  48h  (7  ±  3  mg  vs.  8  ±  5  mg;;  p=  0.320).  (Table  2)  
Morphine-­associated  side  effects  like  nausea  and  vomiting  were  higher  in  the  cFNB  
group  compared  to  the  cFNB  &  ssSNB  group  (8%  vs.  3%;;  p<  0.01).  (Table  2)  
The  functional  scores  were  comparable  between  the  groups  prior  to  surgery  (cFNB  &  
ssSNB:  KSS:  55  [40-­60];;  WOMAC:  4.9  [4-­6]  /  cFNB:  KSS:  50  [40-­65];;  WOMAC:  4.8  
[3.9-­5.8];;  p  =  0.850;;  p  =  0.830)  and  there  was  no  difference  between  the  groups  at  
the  clinical  follow  up  at  3  months  and  12  months.  (Table  3)    
The  incidence  of  cFNB  removal  prior  to  48  hours  due  to  dislocation  was  similar  with  
1%  in  both  groups.  Also  the  incidence  of  reported  stumbling  (5%)  and  reported  falling  
(0.9%)  was  similar  in  both  groups.  (Table  2)  
Morphine-­associated  side  effects  like  nausea  and  vomiting  were  higher  in  the  cFNB  
group  compared  to  the  cFNB  &  ssSNB  group  (8%  vs.  3%;;  p<  0.01).  
     
Seite  11  von  24  
  
6.1.   Tables  
Table  1:  patient  &  surgical  data  
Variables   cFNB  &  ssSNB  group  
(n  =  580)  
cFNB  group  
(n  =  435)  
p-­value  
Sex  (m,f)   260  /  320   180  /  255   0.890  
Age   68  [61-­75]   66.5  [62-­72]   0.325  
BMI  (kg/m2)   26.1  [24.3-­29.3]   27.2  [25.0-­33.7]   0.530  
ASA  I   58  (10%)   65  (14.9%)   0.735  
ASA  II   452  (77.9%)   261  (60%)   0.135  
ASA  III   70  (12.1%)   109  (25.1%)   0.230  
Surgery  time  (min)   116  [105-­125]   117  [103-­128]   0.850  
Surgery  side  (l/r)   330  (56.9%)  /  
250  (43.1  %)  
  
217  (49.9  %)  /  
218  (50.1  %)  
  
0.590  





Blood  loss  (ml)   50  [0-­100]   50  [0-­100]  
  
0.914  
Tourniquet   time  
(min)  
105[85-­120]   110[85-­125]   0.910  
Tourniquet  
pressure  (mmHg)  
280[280-­280]   280[280-­280]   0.900  
Data  shown  as  N  (%),  median  [interquartile  range]  or  mean  ±  standard  deviation  
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Table  2:  Pain  scores  &  morphine  consumption  
Variables   cFNB  &  ssSNB  group  
(n  =  580)  
cFNB  group  
(n  =  435)  
p-­value  
VAS  at  rest  12h   15  ±  5   25  ±  5   0.04*  
VAS  at  rest  24h   15  ±  5   35  ±  7   0.04*  
VAS  at  rest  48h   10  ±  5   10  ±  5   0.850  
Morphine   i.v.   24h  
(mg)  
4  ±  3   11  ±  6   <  0.01*  
Morphine   i.v.   48h  
(mg)  
7  ±  3     8  ±  5   0.320  
Reported  stumbling  
(n)  
29  (5%)   22  (5.1%)   0.800  
Reported  falling  (n)   5  (0.9%)   4  (0.9%)   0.950  
Reported   catheter    
dislocation  (n)  
58  (1%)   43  (1%)   0.900  
Data  shown  as  N  (%),  median  [interquartile  range]  or  mean  ±  standard  deviation  
*  =  statistically  significant  
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Table  3:  Functional  outcome  
Variables   cFNB  &  ssSNB  group   cFNB  group   p-­value  
WOMAC  pre  OP   4.9  [4-­6]   4.8  [3.9-­5.8]   0.830  
WOMAC  at  3m   2.5  [1.5-­3.5]   3.0  [1.9-­4.8]   0.488  
WOMAC  12m   1  [0.5-­2.6]   0.9  [0-­2]   0.890  
KSS  pre  OP   55  [40-­60]   50  [40-­65]   0.850  
KSS  at  3m   91  [70-­92]   88  [55-­94]   0.480  
KSS  12m   95  [88-­99]   89  [70-­95]   0.450  
Data  shown  as  N  (%),  median  [range]  or  mean  ±  standard  deviation  
*  =  statistically  significant  
Legend:  m:  month;;  KSS:  Knee  Society  Score;;  WOMAC:  Western  Ontario  and  
McMaster  Universities  Arthritis  Index  
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7.   Discussion  
7.1.  Main  Findings  
This   study   demonstrates   a   significant   reduction   in   pain   scores   at   rest   adding   a  
ssSNB   to   a   cFNB   group   with   a   reduction   of   morphine   consumption   and   its   side-­
effects   at   12h   and   24h   compared   to   cFNB   alone.   This   better   early   postoperative  
advantage  pain  therapy  does  not  translate  in  a  better  functional  outcome  at  6  weeks  
after  surgery.    
7.2.  Results  in  Context  
The  results  of   this   investigation  are  similar   to  those  published  in  a  recent  review  by  
Grape   S   et   al.   (35)   The   authors   found   that   a   SNB   added   to   a   FNB   significantly  
reduced   resting   pain   scores   at   12h   postoperatively   with   a   mean   difference   of   10  
(95%   CI:   −15   to   −5;;   p<   0.00001).   Moreover,   resting   pain   scores   at   24h,   and  
intravenous  morphine   consumption   at   12h,   24h   and   48h   postoperatively  were   also  
significantly   reduced.  However,   the  authors   found  no  clinical  difference  beyond  12h  
and  no   impact  on   functional  outcomes.  These  findings  are   in  contrast   to   the  review  
by  Paul  JE  et  al.  (12)  where  the  authors  reported  that  the  addition  of  a  sciatic  nerve  
block  or  a  cFNB   to  a  ssFNB  did  not   reduce  morphine  consumption  or  pain  scores.  
This   difference   could   derive   from   the   statistical   analysis   used   in   the   Paul   review  
where  the  Bayesian  inference  methods  were  used  to  compare  treatments  that  were  
not   compared   in   the   same   randomized   control   trial.   (36)   The   authors   chose   this  
method   to   clarify   the   issue   regarding   the   need   to   use   both   the   SNB   and   cFNB  
considering   the   small   amount   of   available   information   from   direct   pairwise  
comparisons   deriving   from   original   randomized   control   trials.   Therefore,   these  
indirect   comparisons   are   not   randomized   and   subject   to   identical   biases   as  
observational   studies.   (37)   In   the   Paul’s   review   only   one   trial   (38) including   36  
patients   addressed   ssFNB   versus   ssFNB   &   ssSNB,   and   only   two   trials   including  
totally  69  patients  compared  ssFNB  versus  cFNB.   (14,  39)  However,  Salinas  et  al.  
(14)  using  ropivacaine  showed  reduced  pain  scores  and  opioid  consumption  using  a  
cFNB,  whereas  Ganapathy  S  et  al.  using  bupivacaine  for   the  cFNB  could  not  show  
this  advantage.  Eventually,   the   faster   resolution  of  motor  and  sensory   function  with  
ropivacaine  blocks  could  have  led  to  this  difference.  (40)    
Other  more  recently  published  studies  have  investigated  the  analgesic  efficacy  of  an  
additional  SNB  to  a  FNB  for  TKA  leading  to  inconclusive  results.  (41,  42)  Additionally,  
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two  additional  systematic  reviews  have  tried  to  quantify  the  analgesic  effect  of  SNB,  
but  showed  conflicting  findings  due  to  the  absence  of  a  statistical  evaluation  (43)  or  
due  to  the  limited  number  of  included  studies  included  with  poor  data  extraction.  (44)  
Despite  the  improvement  in  pain  therapy  in  the  meta-­analysis  by  Grape  S  et  al.  (35)  
with   a   quality   of   evidence   for   the   primary   outcome   based   on   12   RCTs   with   600  
patients,   the   secondary   outcomes   showed   a   quality   of   evidence   varying   from  
moderate   to   very   low.   This   was   mainly   due   to   inconsistency   in   absolute   effects  
observed  and  the  limited  number  of  trials  reporting  several  outcomes.  However,  the  
complication  rate  and  the  functional  outcome  were  not  different  between  the  groups.  
Wegener  J  et  al.  (19)  performed  at  3  and  12  months  postoperatively  a  follow-­up  of  89  
patients   after   TKA   under   FNB   with   or   without   SNB.   They   also   reported   no  
improvement   in   long-­term   physical   function.   However,   a   post-­hoc   analysis   showed  
that   a   small   patient   subgroup   with   limited   pre-­operative   function   might   have  
experienced  reduced  knee  stiffness  12  months  after  surgery.  However,  the  question  
of   SNB   impact   on   short-­term   and   long-­term   functional   outcomes   was   not   further  
assessed   in   other   studies   and   remains   unanswered.   This   lack   of   evidence   in   the  
current   literature   is   of   utmost   importance,   as   alternative   approaches   to   block   the  
sciatic   sensory   distribution   have   been   introduced   in   clinical   practice   such   as   intra-­
operative  local  infiltration  analgesia  (LIA)  with  infiltration  of  the  posterior  joint  capsule  
with   local   anesthetics   and   adjuvants.   Although,   LIA   shows   no   difference   in   i.v.  
morphine  consumption,  pain  scores  at   rest  or  with  motion  on  the  first  postoperative  
day  compared  to  FNB  for  TKA.  (45)  
Despite  the  advantages  of  peripheral  nerve  blocks  for  TKA,  the  clear  lack  of  evidence  
in  the  literature  for  cFNB  compared  to  ssFNB  or  for  the  additional  use  of  SNB  has  to  
be  considered  due  to  the  concern  about  the  issue  of  prolonged  quadriceps  weakness  
after   TKA.   (46,   47)   The   contemporary   incidence   of   neuropathy   after   a   peripheral  
nerve  block  is  according  to  large  databases,  between  0.4,  (48,  49)  and  0.04  (50)  per  
10,000   blocks.   However,   prolonged   quadriceps   weakness   occurs   in   about   2%   of  
patients.  (40)  In  a  case  series  the  rate  of  transient  femoral  neuropathy  after  anterior  
cruciate  ligament  (ACL)  reconstruction  or  TKA  was  between  24%  (51)  and  30%  (52)  
evidenced   by   electrophysiological   studies.   This   complication   has   to   be   considered  
due  to  the  possible  falls  with  potential  fractures  and  delay  in  ambulation.  However,  in  
the  above-­mentioned   reviews   (12,  35)  and   in  other  studies   (53)   the  FNB  group  did  
not   show   a   prolonged   length   of   stay   compared   to   the   PCA   control   group.   As  
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prolonged  quadriceps  weakness  has  also  been  described  without   the  application  of  
regional  anesthesia,  FNB  has  to  be  considered  only  as  one  of  different  risk  factors  for  
this  occurrence.  (54)    
7.3.  Strength  and  Limitations  
The   strength   of   this   review   is   the   high   number   of   patients   analyzed.   Despite   the  
retrospective   character   of   this   work,   all   data   were   collected   from   one   specialized  
center.  On   the  other  hand,   the   review  by  Paul  JE  et  al.   (12)  analyzed  665  patients  
with  FNB  out  of  23  RCT  and   the   review  by  Grape  S  et  al.   (35)  600  patients  out  of  
twelve   randomized   controlled   trials.  Moreover,   patients  were   not   randomized   but   a  
procedure   (cFNB  with   or  without   ssSNB)  was   determined   according   to   the   type   of  
deformity  (varus  or  valgus).    
The   limitations   are   the   retrospective   design,  which   allowed   only   for   assessment   of  
pain  at  rest  without  standardization.    
7.4.  Implications  for  Practice  
The  additional  analgesia  and  morphine  reduction  offered  by  an  additional  ssSNB   is  
considerable  and  could   therefore  be  advised.  However,   the   low  amount  of  patients  
included  in  prospective  studies  and  the  retrospective  design  of  this  Master  Thesis  are  
limiting   factors   to   draw  definitve   conclusions   for   clinical   practice.   If   a   ssSNB   is   not  
possible  for  technical  reasons  or  because  the  surgeon  does  not  want  to  have  the  SN  
blocked,  a  LIA  could  be  added  to  a  cFNB  to  improve  the  analgesic  effect.  (45)  
7.5.  Implications  for  Research  
This  study  shows  that  the  combination  cFNB  &  ssSNB  improved  analgesia  compared  
to  cFNB  alone.  As  mentioned  above,  the  low  number  included  in  the  cited  RCTs,  the  
heterogeneity  of  the  protocols  and  drugs  used  in  those  studies,  the  different  primary  
endpoints  and   the   retrospective  design  of   this   study  are   limiting   factors.  Therefore,  
further   prospective,   randomized   studies   assessing   pain   at   rest   and  with  motion   as  
well  as  functional  outcome  are  warranted  to  highlight  whether  a  better  postoperative  
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7.6.  Conclusions  
The  use  of  and  additional  ssSNB  to  a  cFNB  has  a  better  analgesia  effect  for  the  first  
24  hours  reducing  the  amount  of  opiods  used  and  the  opioid-­associated  nausea  and  
vomiting.   Despite   the   retrospective   design   of   this   study,   the   use   of   an   additional  
ssSNB  to  a  cFNB  can  be  advised  to  achieve  a  better  analgesic  outcome.  However,  
prospective,   randomized   studies   analyzing   the   analgesic   effect   at   rest   and   with  





Seite  18  von  24  
  
8.   References  
  
1.   Rodríguez-­Merchán   EC,   Oussedik   S.   Total   Knee   Arthroplasty   A  
Comprehensive   Guide.   Cham:   Springer   International   Publishing;;   2015.   Online-­
Ressource  p.  
2.   Pinto  PR,  McIntyre  T,  Ferrero  R,  Araujo-­Soares  V,  Almeida  A.  Persistent  pain  
after   total   knee   or   hip   arthroplasty:   differential   study   of   prevalence,   nature,   and  
impact.  J  Pain  Res.  2013;;6:691-­703.  
3.   Puolakka  PA,  Rorarius  MG,  Roviola  M,  Puolakka  TJ,  Nordhausen  K,  Lindgren  
L.   Persistent   pain   following   knee   arthroplasty.   Eur   J  Anaesthesiol.   2010;;27(5):455-­
60.  
4.   Liu  SS,  Buvanendran  A,  Rathmell  JP,  Sawhney  M,  Bae  JJ,  Moric  M,  et  al.  A  
cross-­sectional  survey  on  prevalence  and  risk  factors  for  persistent  postsurgical  pain  
1  year  after  total  hip  and  knee  replacement.  Reg  Anesth  Pain  Med.  2012;;37(4):415-­
22.  
5.   Lewis  GN,  Rice  DA,  McNair  PJ,  Kluger  M.  Predictors  of  persistent  pain  after  
total   knee   arthroplasty:   a   systematic   review   and   meta-­analysis.   Br   J   Anaesth.  
2015;;114(4):551-­61.  
6.   Aguirre  J,  Borgeat  A,  Trachsel  T,  Cobo  Del  Prado   I,  De  Andres  J,  Buhler  P.  
Cerebral   oxygenation   in   patients   undergoing   shoulder   surgery   in   beach   chair  
position:   comparing   general   to   regional   anesthesia   and   the   impact   on  
neurobehavioral  outcome.  Rev  Esp  Anestesiol  Reanim.  2014;;61(2):64-­72.  
7.   Aguirre   J,   Del   Moral   A,   Cobo   I,   Borgeat   A,   Blumenthal   S.   The   role   of  
continuous  peripheral  nerve  blocks.  Anesthesiol  Res  Pract.  2012;;2012:560879.  
8.   Capdevila  X,  Ponrouch  M,  Choquet  O.  Continuous  peripheral  nerve  blocks  in  
clinical  practice.  Curr  Opin  Anaesthesiol.  2008;;21(5):619-­23.  
9.   Liu  JL,  Yuan  WX,  Wang  XL,  Royse  CF,  Gong  MW,  Zhao  Y,  et  al.  Peripheral  
nerve  blocks  versus  general  anesthesia  for  total  knee  replacement  in  elderly  patients  
on  the  postoperative  quality  of  recovery.  Clin  Interv  Aging.  2014;;9:341-­50.  
10.   Blumenthal   S,   Borgeat   A,   Neudorfer   C,   Bertolini   R,   Espinosa   N,   Aguirre   J.  
Additional   femoral  catheter   in  combination  with  popliteal  catheter  for  analgesia  after  
major  ankle  surgery.  Br  J  Anaesth.  2011;;106(3):387-­93.  
11.   Bauer  MCR,  Pogatzki-­Zahn  EM,  Zahn  PK.  Regional  analgesia  techniques  for  
total  knee  replacement.  Current  Opinion  in  Anesthesiology.  2014;;27(5).  
12.   Paul  JE,  Arya  A,  Hurlburt  L,  Cheng  J,  Thabane  L,  Tidy  A,  et  al.  Femoral  nerve  
block  improves  analgesia  outcomes  after  total  knee  arthroplasty:  a  meta-­analysis  of  
randomized  controlled  trials.  Anesthesiology.  2010;;113(5):1144-­62.  
13.   Hadzic  A,  Houle  TT,  Capdevila  X,  Ilfeld  BM.  Femoral  nerve  block  for  analgesia  
in  patients  having  knee  arthroplasty.  Anesthesiology.  2010;;113(5):1014-­5.  
14.   Salinas   FV,   Liu   SS,  Mulroy  MF.   The   effect   of   single-­injection   femoral   nerve  
block  versus  continuous  femoral  nerve  block  after  total  knee  arthroplasty  on  hospital  
length   of   stay   and   long-­term   functional   recovery   within   an   established   clinical  
pathway.  Anesth  Analg.  2006;;102(4):1234-­9.  
Seite  19  von  24  
  
15.   Ilfeld  BM,  Mariano  ER,  Girard  PJ,  Loland  VJ,  Meyer  RS,  Donovan  JF,  et  al.  A  
multicenter,   randomized,   triple-­masked,   placebo-­controlled   trial   of   the   effect   of  
ambulatory   continuous   femoral   nerve   blocks   on   discharge-­readiness   following   total  
knee  arthroplasty   in  patients  on  general  orthopaedic  wards.  Pain.  2010;;150(3):477-­
84.  
16.   Shum  CF,  Lo  NN,  Yeo  SJ,  Yang  KY,  Chong  HC,  Yeo  SN.  Continuous  femoral  
nerve   block   in   total   knee   arthroplasty:   immediate   and   two-­year   outcomes.   J  
Arthroplasty.  2009;;24(2):204-­9.  
17.   Martin   F,  Martinez   V,  Mazoit   JX,   Bouhassira   D,   Cherif   K,   Gentili   ME,   et   al.  
Antiinflammatory   effect   of   peripheral   nerve   blocks   after   knee   surgery:   clinical   and  
biologic  evaluation.  Anesthesiology.  2008;;109(3):484-­90.  
18.   Seet  E,  Leong  WL,  Yeo  AS,  Fook-­Chong  S.  Effectiveness  of  3-­in-­1  continuous  
femoral  block  of  differing  concentrations  compared  to  patient  controlled   intravenous  
morphine  for  post  total  knee  arthroplasty  analgesia  and  knee  rehabilitation.  Anaesth  
Intensive  Care.  2006;;34(1):25-­30.  
19.   Wegener  JT,  van  Ooij  B,  van  Dijk  CN,  Hollmann  MW,  Preckel  B,  Stevens  MF.  
Value  of  single-­injection  or  continuous  sciatic  nerve  block  in  addition  to  a  continuous  
femoral   nerve   block   in   patients   undergoing   total   knee   arthroplasty:   a   prospective,  
randomized,  controlled  trial.  Reg  Anesth  Pain  Med.  2011;;36(5):481-­8.  
20.   Cappelleri  G,  Ghisi  D,  Fanelli  A,  Albertin  A,  Somalvico  F,  Aldegheri  G.  Does  
continuous   sciatic   nerve   block   improve   postoperative   analgesia   and   early  
rehabilitation   after   total   knee   arthroplasty?   A   prospective,   randomized,   double-­
blinded  study.  Reg  Anesth  Pain  Med.  2011;;36(5):489-­92.  
21.   Sundarathiti   P,   Ruananukul   N,   Channum   T,   Kitkunasathean   C,   Mantay   A,  
Thammasakulsiri   J,   et  al.  A  comparison  of   continuous   femoral  nerve  block   (CFNB)  
and   continuous   epidural   infusion   (CEI)   in   postoperative   analgesia   and   knee  
rehabilitation  after  total  knee  arthroplasty  (TKA).  J  Med  Assoc  Thai.  2009;;92(3):328-­
34.  
22.   Zaric  D,  Boysen  K,  Christiansen  C,  Christiansen  J,  Stephensen  S,  Christensen  
B.   A   comparison   of   epidural   analgesia   with   combined   continuous   femoral-­sciatic  
nerve  blocks  after  total  knee  replacement.  Anesth  Analg.  2006;;102(4):1240-­6.  
23.   Mistraletti   G,   De   La   Cuadra-­Fontaine   JC,   Asenjo   FJ,   Donatelli   F,  Wykes   L,  
Schricker   T,   et   al.   Comparison   of   analgesic   methods   for   total   knee   arthroplasty:  
metabolic  effect  of  exogenous  glucose.  Reg  Anesth  Pain  Med.  2006;;31(3):260-­9.  
24.   Hunt  KJ,  Bourne  MH,  Mariani  EM.  Single-­injection   femoral  and  sciatic  nerve  
blocks  for  pain  control  after  total  knee  arthroplasty.  J  Arthroplasty.  2009;;24(4):533-­8.  
25.   Pham  Dang  C,  Gautheron  E,  Guilley  J,  Fernandez  M,  Waast  D,  Volteau  C,  et  
al.  The  value  of  adding  sciatic  block  to  continuous  femoral  block  for  analgesia  after  
total  knee  replacement.  Reg  Anesth  Pain  Med.  2005;;30(2):128-­33.  
26.   Morin   AM,   Kratz   CD,   Eberhart   LH,   Dinges   G,   Heider   E,   Schwarz   N,   et   al.  
Postoperative   analgesia   and   functional   recovery   after   total-­knee   replacement:  
comparison  of   a   continuous  posterior   lumbar   plexus   (psoas   compartment)   block,   a  
continuous   femoral   nerve   block,   and   the   combination   of   a   continuous   femoral   and  
sciatic  nerve  block.  Reg  Anesth  Pain  Med.  2005;;30(5):434-­45.  
Seite  20  von  24  
  
27.   Bagry  H,  de  la  Cuadra  Fontaine  JC,  Asenjo  JF,  Bracco  D,  Carli  F.  Effect  of  a  
continuous  peripheral  nerve  block  on  the  inflammatory  response  in  knee  arthroplasty.  
Reg  Anesth  Pain  Med.  2008;;33(1):17-­23.  
28.   Campbell  A,  McCormick  M,  McKinlay  K,  Scott  NB.  Epidural  vs.  lumbar  plexus  
infusions   following   total   knee   arthroplasty:   randomized   controlled   trial.   Eur   J  
Anaesthesiol.  2008;;25(6):502-­7.  
29.   Frassanito   L,   Vergari   A,   Messina   A,   Pitoni   S,   Puglisi   C,   Chierichini   A.  
Anaesthesia   for   total   knee   arthroplasty:   efficacy   of   single-­injection   or   continuous  
lumbar  plexus  associated  with   sciatic  nerve  blocks-­-­a   randomized  controlled   study.  
Eur  Rev  Med  Pharmacol  Sci.  2009;;13(5):375-­82.  
30.   Watson   MW,   Mitra   D,   McLintock   TC,   Grant   SA.   Continuous   versus   single-­
injection  lumbar  plexus  blocks:  comparison  of  the  effects  on  morphine  use  and  early  
recovery  after  total  knee  arthroplasty.  Reg  Anesth  Pain  Med.  2005;;30(6):541-­7.  
31.   Ilfeld  BM,  Madison  SJ.  The  sciatic  nerve  and  knee  arthroplasty:  to  block,  or  not  
to  block-­-­that  is  the  question.  Reg  Anesth  Pain  Med.  2011;;36(5):421-­3.  
32.   Weber  A,  Fournier  R,  Van  Gessel  E,  Gamulin  Z.  Sciatic  nerve  block  and  the  
improvement   of   femoral   nerve   block   analgesia   after   total   knee   replacement.   Eur   J  
Anaesthesiol.  2002;;19(11):834-­6.  
33.   Abdallah   FW,   Chan   VW,   Koshkin   A,   Abbas   S,   Brull   R.   Ultrasound-­guided  
sciatic   nerve  block   in   overweight   and  obese  patients:   a   randomized   comparison  of  
performance   time   between   the   infragluteal   and   subgluteal   space   techniques.   Reg  
Anesth  Pain  Med.  2013;;38(6):547-­52.  
34.   Kurtz   S,   Ong   K,   Lau   E,   Mowat   F,   Halpern   M.   Projections   of   primary   and  
revision  hip  and  knee  arthroplasty   in   the  United  States   from  2005   to  2030.  J  Bone  
Joint  Surg  Am.  2007;;89(4):780-­5.  
35.   Grape   S,   Kirkham   KR,   Baeriswyl   M,   Albrecht   E.   The   analgesic   efficacy   of  
sciatic   nerve   block   in   addition   to   femoral   nerve   block   in   patients   undergoing   total  
knee   arthroplasty:   a   systematic   review   and   meta-­analysis.   Anaesthesia.  
2016;;71(10):1198-­209.  
36.   Jansen   JP,   Crawford   B,   Bergman   G,   Stam   W.   Bayesian   meta-­analysis   of  
multiple   treatment   comparisons:   an   introduction   to   mixed   treatment   comparisons.  
Value  in  health  :  the  journal  of  the  International  Society  for  Pharmacoeconomics  and  
Outcomes  Research.  2008;;11(5):956-­64.  
37.   Caldwell   DM,   Ades   AE,   Higgins   JP.   Simultaneous   comparison   of   multiple  
treatments:  combining  direct  and  indirect  evidence.  Bmj.  2005;;331(7521):897-­900.  
38.   Allen  HW,  Liu  SS,  Ware  PD,  Nairn  CS,  Owens  BD.  Peripheral   nerve  blocks  
improve   analgesia   after   total   knee   replacement   surgery.   Anesth   Analg.  
1998;;87(1):93-­7.  
39.   Ganapathy  S,  Wasserman  RA,  Watson  JT,  Bennett  J,  Armstrong  KP,  Stockall  
CA,  et  al.  Modified  continuous  femoral  three-­in-­one  block  for  postoperative  pain  after  
total  knee  arthroplasty.  Anesth  Analg.  1999;;89(5):1197-­202.  
40.   Beaulieu  P,  Babin  D,  Hemmerling  T.   The   pharmacodynamics   of   ropivacaine  
and   bupivacaine   in   combined   sciatic   and   femoral   nerve   blocks   for   total   knee  
arthroplasty.  Anesth  Analg.  2006;;103(3):768-­74.  
Seite  21  von  24  
  
41.   Abdallah   FW,   Chan   VW,   Gandhi   R,   Koshkin   A,   Abbas   S,   Brull   R.   The  
analgesic  effects  of  proximal,  distal,  or  no  sciatic  nerve  block  on  posterior  knee  pain  
after   total   knee   arthroplasty:   a   double-­blind   placebo-­controlled   randomized   trial.  
Anesthesiology.  2014;;121(6):1302-­10.  
42.   Safa  B,  Gollish  J,  Haslam  L,  McCartney  CJ.  Comparing   the  effects  of  single  
shot   sciatic   nerve   block   versus   posterior   capsule   local   anesthetic   infiltration   on  
analgesia   and   functional   outcome   after   total   knee   arthroplasty:   a   prospective,  
randomized,  double-­blinded,  controlled  trial.  J  Arthroplasty.  2014;;29(6):1149-­53.  
43.   Abdallah   FW,   Brull   R.   Is   sciatic   nerve   block   advantageous   when   combined  
with   femoral   nerve   block   for   postoperative   analgesia   following   total   knee  
arthroplasty?  A  systematic  review.  Reg  Anesth  Pain  Med.  2011;;36(5):493-­8.  
44.   Abdallah  FW,  Madjdpour  C,  Brull  R.  Is  sciatic  nerve  block  advantageous  when  
combined  with   femoral  nerve  block   for  postoperative  analgesia   following   total   knee  
arthroplasty?  a  meta-­analysis.  Can  J  Anaesth.  2016;;63(5):552-­68.  
45.   Albrecht  E,  Guyen  O,  Jacot-­Guillarmod  A,  Kirkham  KR.  The  analgesic  efficacy  
of   local   infiltration   analgesia   vs   femoral   nerve  block   after   total   knee  arthroplasty:   a  
systematic  review  and  meta-­analysis.  Br  J  Anaesth.  2016;;116(5):597-­609.  
46.   Kandasami   M,   Kinninmonth   AW,   Sarungi   M,   Baines   J,   Scott   NB.   Femoral  
nerve  block  for  total  knee  replacement  -­  a  word  of  caution.  Knee.  2009;;16(2):98-­100.  
47.   Sakai  N,  Nakatsuka  M,  Tomita  T.  Patient-­controlled  bolus  femoral  nerve  block  
after   knee   arthroplasty:   quadriceps   recovery,   analgesia,   local   anesthetic  
consumption.  Acta  Anaesthesiol  Scand.  2016;;60(10):1461-­9.  
48.   Barrington  MJ,  Watts  SA,  Gledhill  SR,  Thomas  RD,  Said  SA,  Snyder  GL,  et  al.  
Preliminary   results   of   the   Australasian   Regional   Anaesthesia   Collaboration:   a  
prospective   audit   of   more   than   7000   peripheral   nerve   and   plexus   blocks   for  
neurologic  and  other  complications.  Reg  Anesth  Pain  Med.  2009;;34(6):534-­41.  
49.   Orebaugh   SL,   Kentor   ML,   Williams   BA.   Adverse   outcomes   associated   with  
nerve  stimulator-­guided  and  ultrasound-­guided  peripheral  nerve  blocks  by  supervised  
trainees:  update  of  a  single-­site  database.  Reg  Anesth  Pain  Med.  2012;;37(6):577-­82.  
50.   Ecoffey  C,  Oger  E,  Marchand-­Maillet  F,  Cimino  Y,  Rannou  JJ,  Beloeil  H,  et  al.  
Complications   associated   with   27   031   ultrasound-­guided   axillary   brachial   plexus  
blocks:   a   web-­based   survey   of   36   French   centres.   Eur   J   Anaesthesiol.  
2014;;31(11):606-­10.  
51.   Albrecht  E,  Niederhauser  J,  Gronchi  F,  Locherbach  C,  Kombot  C,  Rossat  J,  et  
al.   Transient   femoral   neuropathy   after   knee   ligament   reconstruction   and   nerve  
stimulator-­guided   continuous   femoral   nerve   block:   a   case   series.   Anaesthesia.  
2011;;66(9):850-­1.  
52.   Engelhardt  P,  Roder  R,  Kohler  M.  [Neurologic  complications  in  implantation  of  
knee   endoprostheses.   A   clinical   and   EMG-­documented   study].   Z   Orthop   Ihre  
Grenzgeb.  1987;;125(2):190-­3.  
53.   Crowley   C,   Dowsey   MM,   Quinn   C,   Barrington   M,   Choong   PF.   Impact   of  
regional  and   local  anaesthetics  on   length  of  stay   in  knee  arthroplasty.  ANZ  J  Surg.  
2012;;82(4):207-­14.  
Seite  22  von  24  
  
54.   Dwyer   T,   Drexler   M,   Chan   VW,   Whelan   DB,   Brull   R.   Neurological  
Complications   Related   to   Elective   Orthopedic   Surgery:   Part   2:   Common   Hip   and  
Knee  Procedures.  Reg  Anesth  Pain  Med.  2015;;40(5):443-­54.  
  
     
Seite  23  von  24  
  
9.   Curriculum  Vitae  
  
Name,  Vorname  (n)                  Bischoff,  Sabrina  
Geschlecht:   weiblich  
Geburtsdatum:   30.05.1991    
Heimatort  und  Kanton            
Birwinken  TG  
  
Ausbildung:   1998  –  2001  Pächterried,  Watt                              
   2001  –  2004  Chrüzacher,  Regensdorf  
   2004  –  2010  Kantonsschule  Oerlikon,  Zürich,  
                                             Altsprachliches  Profil  




















Ich   erkläre   ausdrücklich,   dass   es   sich   bei   der   von   mir   im   Rahmen   des   Studiengangs  
Humanmedizin  eingereichten  schriftlichen  Arbeit  mit  dem  Titel  
  
The   Impact   of   Regional   Anesthesia   on   Analgesia   Outcome   after   Total   Knee  
Replacement:  A  Retrospective  Study  
  
um   eine   von   mir   selbst   und   ohne   unerlaubte   Beihilfe   sowie   in   eigenen   Worten   verfasste  
Masterarbeit*  handelt.    
Ich  bestätige  überdies,  dass  die  Arbeit  als  Ganzes  oder   in  Teilen  weder  bereits  einmal  zur  
Abgeltung   anderer   Studienleistungen   an   der   Universität   Zürich   oder   an   einer   anderen  
Universität  oder  Ausbildungseinrichtung  eingereicht  worden  ist.  
  
Verwendung  von  Quellen  
Ich   erkläre   ausdrücklich,   dass   ich   sämtliche   in   der   oben   genannten   Arbeit   enthaltenen  
Bezüge   auf   fremde   Quellen   (einschliesslich   Tabellen,   Grafiken   u.   Ä.)   als   solche   kenntlich  
gemacht  habe.  Insbesondere  bestätige  ich,  dass  ich  ausnahmslos  und  nach  bestem  Wissen  
sowohl   bei   wörtlich   übernommenen   Aussagen   (Zitaten)   als   auch   bei   in   eigenen   Worten  
wiedergegebenen   Aussagen   anderer   Autorinnen   oder   Autoren   (Paraphrasen)   die  
Urheberschaft  angegeben  habe.  
  
Sanktionen  
Ich   nehme   zur   Kenntnis,   dass   Arbeiten,   welche   die   Grundsätze   der  
Selbstständigkeitserklärung   verletzen   –   insbesondere   solche,   die   Zitate   oder   Paraphrasen  
ohne  Herkunftsangaben  enthalten  –,  als  Plagiat  betrachtet  werden  und  die  entsprechenden  
rechtlichen   und   disziplinarischen   Konsequenzen   nach   sich   ziehen   können   (gemäss   §§   7ff  
der  Disziplinarordnung  der  Universität  Zürich  sowie  §§  51ff  der  Rahmenverordnung   für  das  
Studium   in   den   Bachelor-­   und   Master-­Studiengängen   an   der   Medizinischen   Fakultät   der  
Universität  Zürich  
  








*  Falls  die  Masterarbeit  eine  Publikation  enthält,  bei  der   ich  Erst-­  oder  Koautor/-­in  bin,  wird  
meine  eigene  Arbeitsleistung  im  Begleittext  detailliert  und  strukturiert  beschrieben.  
